ANTI-NEUTROPHIL NUCLEAR ANTIBODY IN INFLAMMATORY BOWEL-DISEASE AND PRIMARY SCLEROSING CHOLANGITIS

ANTI-NEUTROPHIL NUCLEAR ANTIBODY IN INFLAMMATORY BOWEL-DISEASE AND PRIMARY SCLEROSING CHOLANGITIS

Opis bibliograficzny
Główni autorzy:	Snook, J, Chapman, R, Fleming, K, Jewell, D
Format:	Journal article
Wydane:	1988

Podobne zapisy

Anti-neutrophil nuclear antibody in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis.
od: Snook, J, i wsp.
Wydane: (1989)

The immunogenetic basis for anti-neutrophil cytoplasmic antibody production in primary sclerosing cholangitis and ulcerative colitis.
od: Mehal, W, i wsp.
Wydane: (1994)

PORTAL TRACT LYMPHOCYTE POPULATIONS IN PRIMARY SCLEROSING CHOLANGITIS
od: Snook, J, i wsp.
Wydane: (1987)

Prevalence of anti-neutrophil antibody in primary sclerosing cholangitis and ulcerative colitis using an alkaline phosphatase technique.
od: Lo, S, i wsp.
Wydane: (1992)

ANTINEUTROPHIL ANTIBODY AND PRIMARY SCLEROSING CHOLANGITIS
od: Lo, S, i wsp.
Wydane: (1991)

Primary sclerosing cholangitis--an immunologically mediated disease?
od: Chapman, R, i wsp.
Wydane: (1985)

Primary sclerosing cholangitis, autoimmune hepatitis and overlap syndromes in inflammatory bowel disease.
od: Saich, R, i wsp.
Wydane: (2008)

Peripheral blood and portal tract lymphocyte populations in primary sclerosing cholangitis.
od: Snook, J, i wsp.
Wydane: (1989)

Fibrolamellar hepatocellular carcinoma complicating ulcerative colitis with primary sclerosing cholangitis.
od: Snook, J, i wsp.
Wydane: (1989)

Treatment of primary sclerosing cholangitis combined with inflammatory bowel disease
od: You Sun Kim, i wsp.
Wydane: (2023-10-01)

The enigma of anti-neutrophil antibodies in ulcerative colitis primary sclerosing cholangitis: important genetic marker or epiphenomenon?
od: Chapman, R
Wydane: (1995)

International experience of vedolizumab in primary sclerosing cholangitis and inflammatory bowel disease
od: Williamson, K, i wsp.
Wydane: (2018)

SERUM ANTI-COLON ANTIBODIES, ULCERATIVE-COLITIS, AND SCLEROSING CHOLANGITIS
od: Chapman, R, i wsp.
Wydane: (1983)

Effects of vedolizumab in patients with primary sclerosing cholangitis and inflammatory bowel diseases
od: Lynch, K, i wsp.
Wydane: (2019)

Chromoendoscopy in colorectal surveillance for primary sclerosing cholangitis and inflammatory bowel disease
od: Rodrigo V Motta, i wsp.
Wydane: (2025-01-01)

CCR5 Delta 32 polymorphism in inflammatory bowel disease: Further association with ulcerative colitis and with primary sclerosing cholangitis.
od: Satsangi, J, i wsp.
Wydane: (2000)

Cholangiocarcinoma in primary sclerosing cholangitis is associated with long-standing inflammatory bowel disease. A long-term follow-up of 394 primary sclerosing cholangitis patients.
od: Boberg, K, i wsp.
Wydane: (2001)

Primary sclerosing cholangitis
od: Chapman, R
Wydane: (2007)

Primary sclerosing cholangitis.
od: Chapman, R
Wydane: (1985)

Primary sclerosing cholangitis.
od: Cullen, S, i wsp.
Wydane: (2003)

Primary sclerosing cholangitis.
od: Mitchell, SA, i wsp.
Wydane: (2000)

Primary sclerosing cholangitis.
od: Williamson, K, i wsp.
Wydane: (2014)

Primary sclerosing cholangitis.
od: Worthington, J, i wsp.
Wydane: (2006)

Primary sclerosing cholangitis
od: Chapman Roger, i wsp.
Wydane: (2006-10-01)

Mortality and extraintestinal cancers in patients with primary sclerosing cholangitis and inflammatory bowel disease
od: Ananthakrishnan, Ashwin N., i wsp.
Wydane: (2016)

Autoimmune hepatitis and primary sclerosing cholangitis overlap syndrome in inflammatory bowel diseases
od: Joanna Saganek, i wsp.
Wydane: (2023-09-01)

Regional variations in the prevalence of primary sclerosing cholangitis associated with inflammatory bowel disease
od: Kwang Woo Kim, i wsp.
Wydane: (2023-10-01)

Low prevalence of primary sclerosing cholangitis in patients with inflammatory bowel disease in India
od: Arshdeep Singh, i wsp.
Wydane: (2023-10-01)

Contrasting Pattern of Chronic Inflammatory Bowel Disease in Primary and Autoimmune Sclerosing Cholangitis
od: Ingvar Bjarnason, i wsp.
Wydane: (2015-10-01)

Characterisation of the antigen for the antineutrophil cytoplasmic antibody specific for primary sclerosing cholangitis
od: Cameron, B, i wsp.
Wydane: (1998)

ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES AFTER LIVER-TRANSPLANTATION FOR PRIMARY SCLEROSING CHOLANGITIS
od: Bansi, D, i wsp.
Wydane: (1995)

A 2-year follow-up study of anti-neutrophil antibody in primary sclerosing cholangitis: relationship to clinical activity, liver biochemistry and ursodeoxycholic acid treatment.
od: Lo, S, i wsp.
Wydane: (1994)

SERUM PROCOLLAGEN III N-TERMINAL PEPTIDE IN PRIMARY SCLEROSING CHOLANGITIS
od: Snook, J, i wsp.
Wydane: (1988)

INTERFERON-GAMMA PRODUCTION IN PRIMARY SCLEROSING CHOLANGITIS
od: Martins, E, i wsp.
Wydane: (1995)

FEMALES WITH PRIMARY SCLEROSING CHOLANGITIS WITHOUT INFLAMMATORY BOWEL DISEASES HAVE A BETTER PROGNOSIS: IS IT DIFFERENT DISEASE?
od: Al Mamari, S, i wsp.
Wydane: (2013)

The management of primary sclerosing cholangitis.
od: Chapman, R
Wydane: (2003)

The immunology of primary sclerosing cholangitis.
od: Chapman, R
Wydane: (1990)

Primary sclerosing cholangitis - Foreword
od: Chapman, R
Wydane: (2006)

THE IMMUNOGENETICS OF PRIMARY SCLEROSING CHOLANGITIS
od: Chapman, R
Wydane: (1993)

IGG SUBCLASS DISTRIBUTION OF ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES IN PRIMARY SCLEROSING CHOLANGITIS AND ULCERATIVE-COLITIS
od: Bansi, D, i wsp.
Wydane: (1995)